NKGen (NKGN): Kapitalisasi pasar

NKGen Biotech, Inc. (NKGN) focuses on independently conducting clinical trials against Alzheimer's disease while leveraging academic partners for funding. The company is implementing AI bioreactors to automate cell cultivation and reduce manual labor costs. This daily price chart for the company on GURU.Markets reflects a level of 0.01. The business is also expanding its profile by developing NK-cell-based therapies for cancer and neurodegeneration.

NKGN NKGen Biotech: Kapitalisasi pasar ing interval 21.02.2024 - 15.03.2025

NKGN (NKGen Biotech Corp): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji NKGen Biotech, Inc. (NKGN):
Bagan rega NKGen Biotech|NKGN - Prakiraan konsensus analis|Kapitalisasi pasar NKGen Biotech Corp
Analisis fundamental perusahaan:NKGN (NKGen Biotech)

The resilience of NKGen Biotech, Inc. (NKGN) depends on the stability of global supply chains and patent protection. These factors directly impact the market value of all shares, determined by the product of the current price and the number of securities. This metric reflects the real-time assessment of the business by investors. Sharp fluctuations in the company's market capitalization signal high volatility. Peak values on the chart often precede deep corrections.

Pesaing wigati

Nilai pasar Biogen BIIB|Kapitalisasi pasar Neurocrine NBIX|Regencell - Kapitalisasi pasar|Kapitalisasi pasar Axsome Corp (AXSM)|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Kapitalisasi pasar XENE|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|Kapitalisasi pasar PRTA (Prothena Corp)|Nilai pasar Alector, Inc. (ALEC)|Kapitalisasi pasar Annexon Biosciences (ANNX)|Kapitalisasi pasar OMER (Omeros)|Kapitalisasi pasar Neurogene Therapeutics|AC Immune - Kapitalisasi pasar|Nilai pasar voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Nilai pasar|Kapitalisasi pasar SCLX|Biji pasar TVGN|ACOG: Nilai pasar|Kapitalisasi pasar CGTX|Nilai pasar IKT (inhibikase.com)|Kapitalisasi pasar SAVA (Cassava Sciences)|Kapitalisasi pasar Assertio Holdings (ASRT)|COYA - Nilai pasar|Nilai pasar Vistagen Therapeutics|OVID (ovidrx.com) - Biji pasar|ABOS: Nilai pasar|CRVO (CervoMed) - Kapitalisasi pasar|Nilai pasar Alterity Therapeutics Ltd ATHE|Kapitalisasi pasar CLNN|Biji pasar pepgen.com PEPG|Kapitalisasi pasar JUNS (Jupiter Neurosciences)|Nilai pasar RLMD|ANVS: Biji pasar|Nilai pasar GRCE (Grace Therapeutics, Inc.)|AIFF: Kapitalisasi pasar|KLTO - Kapitalisasi pasar|Nilai pasar NeuroSense Therapeutics Ltd|Kapitalisasi pasar RVPH (revivapharma.com)|Kapitalisasi pasar MTVA|Biji pasar NeurAxis Inc. NRXS|Helius Medical Technologies - Biji pasar|Kapitalisasi pasar Passage Bio Inc. (PASG)|NEUP - Nilai pasar|NERV (minervaneurosciences.com) - Kapitalisasi pasar|Athira Pharma (ATHA) - Nilai pasar|Addex Therapeutics Ltd. (ADXN) - Kapitalisasi pasar|ALZN (Alzamend Neuro Inc.) - Kapitalisasi pasar|CYCN - Kapitalisasi pasar|Nilai pasar Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Kapitalisasi pasar|Nilai pasar Cortigent CRGT|ATXI: Kapitalisasi pasar|Brainstorm Cell Therapeutics, Inc. - Kapitalisasi pasar|Nilai pasar Cara Therapeutics Inc|CHRO (Chromocell Therapeutics) - Biji pasar|Eliem Therapeutics Inc. (ELYM) - Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies Inc.|LBPH: Nilai pasar|Nilai pasar Marinus (MRNS)|NRBO - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|SNPX: Kapitalisasi pasar|TRVN - Nilai pasar|VIGL - Kapitalisasi pasar|WENA: Kapitalisasi pasar|Kapitalisasi pasar Cerevel Corp CERE